+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Smart Drugs & Pills Market Research Report by Target Area (Esophagus, Large Intestine, and Small Intestine), End User, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 242 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5337889
UP TO OFF until Dec 31st 2022
The Global Smart Drugs & Pills Market size was estimated at USD 4,262.38 million in 2021, USD 5,124.99 million in 2022, and is projected to grow at a CAGR 20.41% to reach USD 12,993.72 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Smart Drugs & Pills to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Target Area, the market was studied across Esophagus, Large Intestine, Small Intestine, and Stomach.
  • Based on End User, the market was studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on Application, the market was studied across Capsule Endoscopy, Drug Delivery, and Patient Monitoring.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Smart Drugs & Pills market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smart Drugs & Pills Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Smart Drugs & Pills Market, including Acamp, Bio-Images Research Limited, Boston Scientific Corporation, CapsoVision, Inc., Cerner Corporation, Fujifilm Holdings Corporation, GE Healthcare, Given Imaging, Inc., Karl Storz Gmbh & Co. KG, Medimetrics S.A. de C.V., MediSafe, Medtronic, Olympus Corporation, Pentax Medical Company, and Proteus Digital Health.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Smart Drugs & Pills Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Smart Drugs & Pills Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smart Drugs & Pills Market?
4. What is the competitive strategic window for opportunities in the Global Smart Drugs & Pills Market?
5. What are the technology trends and regulatory frameworks in the Global Smart Drugs & Pills Market?
6. What is the market share of the leading vendors in the Global Smart Drugs & Pills Market?
7. What modes and strategic moves are considered suitable for entering the Global Smart Drugs & Pills Market?
Frequently Asked Questions about the Global Smart Drugs & Pills Market

What is the estimated value of the Global Smart Drugs & Pills Market?

The Global Smart Drugs & Pills Market was estimated to be valued at $4262.38 Million in 2021.

What is the growth rate of the Global Smart Drugs & Pills Market?

The growth rate of the Global Smart Drugs & Pills Market is 20.4%, with an estimated value of $12993.72 Million by 2027.

What is the forecasted size of the Global Smart Drugs & Pills Market?

The Global Smart Drugs & Pills Market is estimated to be worth $12993.72 Million by 2027.

Who are the key companies in the Global Smart Drugs & Pills Market?

Key companies in the Global Smart Drugs & Pills Market include Acamp, Bio, Images Research Limited, Boston Scientific Corporation, CapsoVision, Inc., Cerner Corporation, Fujifilm Holdings Corporation, GE Healthcare and Karl Storz Gmbh & Co. KG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Preference for Less Complex and Painful Diagnostic Examinations with Minimally Invasive Surgeries
5.1.1.2. Increasing Popularity of Smart Drug to Achieve Cognitive Enhancement
5.1.1.3. Rise in Prevalence of Gastrointestinal Disorders and Colon Cancer
5.1.1.4. Proactive Approach to Cure the Potential Illness
5.1.1.5. Technological Advancements in Capsule Endoscopes
5.1.1.6. Increased R&D Investments in Developing Smart Pills
5.1.2. Restraints
5.1.2.1. Ethical and Social Constraints
5.1.2.2. Potential Health Risk
5.1.3. Opportunities
5.1.3.1. Rise in Technological Advances Pertaining to Smart Pills Such as Bioelectronics, Availability of Microprocessors, Micro-Cameras, Miniaturization,
5.1.3.2. Rapid Development in the Smart Drugs and Pills Development Process
5.1.4. Challenges
5.1.4.1. Stringent Government Regulations Regarding the Increased Use of These Devices
5.1.4.2. High Cost Associated with the Ingestible Sensors
5.2. Cumulative Impact of COVID-19
6. Smart Drugs & Pills Market, by Target Area
6.1. Introduction
6.2. Esophagus
6.3. Large Intestine
6.4. Small Intestine
6.5. Stomach
7. Smart Drugs & Pills Market, by End-user
7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
7.4. Research Institutes
8. Smart Drugs & Pills Market, by Application
8.1. Introduction
8.2. Capsule Endoscopy
8.3. Drug Delivery
8.4. Patient Monitoring
9. Americas Smart Drugs & Pills Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Smart Drugs & Pills Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Smart Drugs & Pills Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Acamp
13.2. Bio-Images Research Limited
13.3. Boston Scientific Corporation
13.4. Capsovision, Inc.
13.5. Cerner Corporation
13.6. Fujifilm Holdings Corporation
13.7. GE Healthcare
13.8. Given Imaging, Inc.
13.9. Karl Storz GmbH & Co. Kg
13.10. Medimetrics S.A. De C.V.
13.11. Medisafe
13.12. Medtronic
13.13. Olympus Corporation
13.14. Pentax Medical Company
13.15. Proteus Digital Health
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL SMART DRUGS & PILLS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL SMART DRUGS & PILLS MARKET DYNAMICS
FIGURE 8. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2021 VS 2027 (%)
FIGURE 9. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2027
FIGURE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 20. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2027
FIGURE 22. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 29. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2027
FIGURE 31. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 39. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2027
FIGURE 41. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. BRAZIL SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. CANADA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. MEXICO SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 47. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2027
FIGURE 49. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. CHINA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. INDIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. INDONESIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. JAPAN SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. TAIWAN SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. THAILAND SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2027
FIGURE 68. FRANCE SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. GERMANY SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. ITALY SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. QATAR SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. RUSSIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. SPAIN SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. GLOBAL SMART DRUGS & PILLS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 80. GLOBAL SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SMART DRUGS & PILLS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL SMART DRUGS & PILLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 63. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 65. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 66. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 67. BRAZIL SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 69. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 70. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 71. CANADA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 73. CANADA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 74. CANADA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 75. MEXICO SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 77. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 78. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 82. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 88. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 89. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 91. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 92. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 93. CHINA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 95. CHINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 96. CHINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 97. INDIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 99. INDIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 100. INDIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 101. INDONESIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 103. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 104. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 105. JAPAN SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 107. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 108. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 109. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 111. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 112. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 113. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 115. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 116. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 117. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 119. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 120. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 121. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 122. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 123. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 124. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 125. TAIWAN SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 127. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 128. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 129. THAILAND SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 131. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 132. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 138. FRANCE SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 140. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 141. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 142. GERMANY SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 144. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 145. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. ITALY SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 147. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 148. ITALY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 149. ITALY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 150. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 152. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 153. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 154. QATAR SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 155. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 156. QATAR SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 157. QATAR SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 158. RUSSIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 160. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 161. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 162. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 164. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 165. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 166. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 167. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 168. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 169. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 170. SPAIN SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 172. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 173. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 178. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2019-2027 (USD MILLION)
TABLE 180. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 181. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 182. GLOBAL SMART DRUGS & PILLS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 183. GLOBAL SMART DRUGS & PILLS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 184. GLOBAL SMART DRUGS & PILLS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 185. GLOBAL SMART DRUGS & PILLS MARKET RANKING
TABLE 186. GLOBAL SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 187. GLOBAL SMART DRUGS & PILLS MARKET MERGER & ACQUISITION
TABLE 188. GLOBAL SMART DRUGS & PILLS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 189. GLOBAL SMART DRUGS & PILLS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 190. GLOBAL SMART DRUGS & PILLS MARKET INVESTMENT & FUNDING
TABLE 191. GLOBAL SMART DRUGS & PILLS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 192. GLOBAL SMART DRUGS & PILLS MARKET: LICENSE & PRICING

Companies Mentioned

  • Acamp
  • Bio-Images Research Limited
  • Boston Scientific Corporation
  • CapsoVision, Inc.
  • Cerner Corporation
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Given Imaging, Inc.
  • Karl Storz Gmbh & Co. KG
  • Medimetrics S.A. de C.V.
  • MediSafe
  • Medtronic
  • Olympus Corporation
  • Pentax Medical Company
  • Proteus Digital Health

Methodology

Loading
LOADING...